nadifloxacin has been researched along with Skin Diseases, Infectious in 1 studies
nadifloxacin: (R)-isomer does not induce chromosomal aberrations, unlike (S)-isomer; structure given in first source
Skin Diseases, Infectious: Skin diseases caused by bacteria, fungi, parasites, or viruses.
Excerpt | Relevance | Reference |
---|---|---|
"Nadifloxacin (NDFX) is a fluoroquinolone antibiotic developed by Otsuka Pharmaceutical Co." | 1.33 | [Antibacterial activity of nadifloxacin against Staphylococcus and Propionibacterium isolated from patients with dermatological infections]. ( Hasegawa, M; Kobayashi, I; Matsuzaki, K; Omika, K; Sato, Y, 2006) |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (100.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Matsuzaki, K | 1 |
Omika, K | 1 |
Hasegawa, M | 1 |
Sato, Y | 1 |
Kobayashi, I | 1 |
1 other study available for nadifloxacin and Skin Diseases, Infectious
Article | Year |
---|---|
[Antibacterial activity of nadifloxacin against Staphylococcus and Propionibacterium isolated from patients with dermatological infections].
Topics: Anti-Infective Agents; Fluoroquinolones; Humans; Methicillin Resistance; Propionibacterium; Quinoliz | 2006 |